1
|
Klonoff DC, Xu NY, Nguyen KT, Kerr D, Mehta C, Umpierrez GE, Brooks GA. Trimetazidine Blocks Lipid Oxidation-Should it be Repurposed for Prevention and Treatment of Diabetic Ketoacidosis? J Diabetes Sci Technol 2022; 16:1063-1068. [PMID: 35652624 PMCID: PMC9445353 DOI: 10.1177/19322968221100196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- David C. Klonoff
- Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA
| | - Nicole Y. Xu
- Diabetes Technology Society, Burlingame, CA, USA
| | | | - David Kerr
- Sansum Diabetes Research Institute, Santa Barbara, CA, USA
| | - Chhavi Mehta
- Palo Alto Foundation Medical Group, Burlingame, CA, USA
| | | | - George A. Brooks
- Integrative Biology, University of California, Berkeley, Berkeley, CA, USA
| |
Collapse
|